✦ LIBER ✦

PCV73 Prevention of Stroke in Patients With Atrial Fibrillation: Cost-Utility Analysis of Rivaroxaban Versus Warfarin in Slovakia

✍ Scribed by M. Psenkova; M. Lukac; S. Mackovicova; M. Stachova; J. Bielik; G.A. Pietsch; Y. Asukai; A. Lloyd; T. Evers

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost–Effectiveness of Rivaroxaban Compar

✍ Soyon Lee; Moise W. Anglade; Dan Pham; Robyn Pisacane; Jeffrey Kluger; Craig I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 786 KB

PCV49 Economic Evaluation of Rivaroxaban

✍ G. Kourlaba; N. Maniadakis; G. Andrikopoulos; P. Vardas; A. Llyod; Y. Asukai; T. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV72 Cost-Effectiveness of Rivaroxaban

✍ G. Restovic; D. Carcedo; E.J. McLeod; A.L.G. Guillermin; T. Evers 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-effectiveness of warfarin: Trial ve

✍ Sonja V. Sorensen; Sarah Dewilde; Daniel E. Singer; Samuel Z. Goldhaber; Brigitt 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 420 KB

PCV93 THROMBOPROPHYLAXIS AFTER TOTAL KNE

✍ M Lukac; J Bielik; M Lees; D Tomek; V Foltan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB